Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Changes in sleep predict changes in depressive symptoms in depressed subjects receiving vortioxetine: An open-label clinical trial.

Cao B, Park C, Rosenblat JD, Chen Y, Iacobucci M, Subramaniapillai M, Mansur RB, Zuckerman H, Lee Y, McIntyre RS.

J Psychopharmacol. 2019 Nov;33(11):1388-1394. doi: 10.1177/0269881119874485. Epub 2019 Sep 18.

PMID:
31530216
2.

The Efficacy of Vortioxetine on Anhedonia in Patients With Major Depressive Disorder.

Cao B, Park C, Subramaniapillai M, Lee Y, Iacobucci M, Mansur RB, Zuckerman H, Phan L, McIntyre RS.

Front Psychiatry. 2019 Jan 31;10:17. doi: 10.3389/fpsyt.2019.00017. eCollection 2019.

3.

Preliminary evidence that vortioxetine may improve sleep quality in depressed patients with insomnia: a retrospective questionnaire analysis.

Liguori C, Ferini-Strambi L, Izzi F, Mari L, Manfredi N, D'Elia A, Mercuri NB, Placidi F.

Br J Clin Pharmacol. 2019 Jan;85(1):240-244. doi: 10.1111/bcp.13772. Epub 2018 Oct 24.

PMID:
30328132
4.

Effects of Adjunctive Brexpiprazole on Sleep Disturbances in Patients With Major Depressive Disorder: An Open-Label, Flexible-Dose, Exploratory Study.

Krystal AD, Mittoux A, Meisels P, Baker RA.

Prim Care Companion CNS Disord. 2016 Sep 8;18(5). doi: 10.4088/PCC.15m01914.

5.

3111T/C clock gene polymorphism is not associated with sleep disturbances in untreated depressed patients.

Serretti A, Gaspar-Barba E, Calati R, Cruz-Fuentes CS, Gomez-Sanchez A, Perez-Molina A, De Ronchi D.

Chronobiol Int. 2010 Jan;27(2):265-77. doi: 10.3109/07420521003663785.

PMID:
20370469
6.

Vortioxetine for depression in adults.

Koesters M, Ostuzzi G, Guaiana G, Breilmann J, Barbui C.

Cochrane Database Syst Rev. 2017 Jul 5;7:CD011520. doi: 10.1002/14651858.CD011520.pub2. Review.

7.

Effect of sertraline on breathing in depressed patients without moderate-to-severe sleep-related breathing disorders.

Zhang B, Hao Y, Jia F, Li X, Tang Y, Zheng H, Liu W.

Sleep Breath. 2015 Dec;19(4):1377-86. doi: 10.1007/s11325-015-1152-8. Epub 2015 Mar 11.

PMID:
25758299
8.

Long-term functioning outcomes are predicted by cognitive symptoms in working patients with major depressive disorder treated with vortioxetine: results from the AtWoRC study.

Chokka P, Bougie J, Proulx J, Tvistholm AH, Ettrup A.

CNS Spectr. 2019 Feb 25:1-12. doi: 10.1017/S1092852919000786. [Epub ahead of print]

PMID:
30802419
9.

Other Antidepressants.

Schwasinger-Schmidt TE, Macaluso M.

Handb Exp Pharmacol. 2019;250:325-355. doi: 10.1007/164_2018_167.

PMID:
30194544
10.
11.

Association between cognitive function and performance on effort based decision making in patients with major depressive disorder treated with Vortioxetine.

Subramaniapillai M, Mansur RB, Zuckerman H, Park C, Lee Y, Iacobucci M, Cao B, Ho R, Lin K, Phan L, McIntyre RS.

Compr Psychiatry. 2019 Oct;94:152113. doi: 10.1016/j.comppsych.2019.07.006. Epub 2019 Jul 24.

12.

Subjective sleep disturbance in Chinese adults with epilepsy: Associations with affective symptoms.

Shen Y, Zhang M, Wang Y, Wang L, Xu X, Xiao G, Chen J, Zhang T, Zhou N.

Epilepsy Res. 2017 Sep;135:150-157. doi: 10.1016/j.eplepsyres.2017.06.014. Epub 2017 Jul 1.

PMID:
28697489
13.

Effects of a Course of Right Unilateral Ultrabrief Pulse Electroconvulsive Therapy Combined With Venlafaxine on Insomnia Symptoms in Elderly Depressed Patients.

McCall WV, Lisanby SH, Rosenquist PB, Dooley M, Husain MM, Knapp RG, Petrides G, Rudorfer MV, Young RC, McClintock SM, Mueller M, Prudic J, Greenberg RM, Weiner RD, Bailine SH, Riley MA, McCloud L, Kellner CH; CORE/PRIDE Work Group.

J Clin Psychiatry. 2018 Mar/Apr;79(2). pii: 16m11089. doi: 10.4088/JCP.16m11089.

14.

Symptom reports in severe chronic insomnia.

Moul DE, Nofzinger EA, Pilkonis PA, Houck PR, Miewald JM, Buysse DJ.

Sleep. 2002 Aug 1;25(5):553-63.

PMID:
12150322
15.

Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial.

Fava M, Asnis GM, Shrivastava RK, Lydiard B, Bastani B, Sheehan DV, Roth T.

J Clin Psychiatry. 2011 Jul;72(7):914-28. doi: 10.4088/JCP.09m05571gry. Epub 2010 Dec 28.

PMID:
21208597
16.

Subjective sleep quality, objective sleep characteristics, insomnia symptom severity, and daytime sleepiness in women aged 50 and older with nonmetastatic breast cancer.

Enderlin CA, Coleman EA, Cole C, Richards KC, Kennedy RL, Goodwin JA, Hutchins LF, Mack K.

Oncol Nurs Forum. 2011 Jul;38(4):E314-25. doi: 10.1188/11.ONF.E314-E325.

PMID:
21708527
17.

Randomized, 8-week, double-blind, placebo-controlled trial of vortioxetine in Japanese adults with major depressive disorder, followed by a 52-week open-label extension trial.

Inoue T, Nishimura A, Sasai K, Kitagawa T.

Psychiatry Clin Neurosci. 2018 Feb;72(2):103-115. doi: 10.1111/pcn.12623. Epub 2017 Dec 27.

18.

Randomized, double-blind, placebo-controlled 8-week trial of the efficacy, safety, and tolerability of 5, 10, and 20 mg/day vortioxetine in adults with major depressive disorder.

Nishimura A, Aritomi Y, Sasai K, Kitagawa T, Mahableshwarkar AR.

Psychiatry Clin Neurosci. 2018 Feb;72(2):64-72. doi: 10.1111/pcn.12565. Epub 2017 Oct 3.

19.

Perceived sleep quality predicts cognitive function in adults with major depressive disorder independent of depression severity.

Cha DS, Carmona N, Cha RH, Zhou AJ, Subramaniapillai M, Mansur RB, Lee Y, Lee JH, Lee J, Almatham F, Alageel A, Rosenblat JD, Shekotikhina M, Rong C, Harrison J, McIntyre RS.

Ann Clin Psychiatry. 2019 Feb;31(1):17-26.

PMID:
30372511
20.

Electroacupuncture for residual insomnia associated with major depressive disorder: a randomized controlled trial.

Yeung WF, Chung KF, Tso KC, Zhang SP, Zhang ZJ, Ho LM.

Sleep. 2011 Jun 1;34(6):807-15. doi: 10.5665/SLEEP.1056.

Supplemental Content

Support Center